Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Geographic Atrophy > Early changes in retinal structures may predict AMD progression patterns
  • Geographic Atrophy

Early changes in retinal structures may predict AMD progression patterns

Kelsey Moroz

Changes in the ganglion cell complex (GCC) and choroidal thickness can serve as early indicators of progression patterns in age-related macular degeneration (AMD), according to a study that suggested these structural variations may help differentiate between atrophic and neovascular progression.

In this retrospective cohort study, data from 64 patients aged 50 and older with early or intermediate AMD, with no signs of advanced disease were analyzed. Patients were categorized into 4 groups based on the Rotterdam classification and underwent spectral domain optical coherence tomography (SD-OCT) imaging at 2 time points over a minimum interval of 3 years.

The study found significant thinning of the GCC inner ring in the atrophic AMD group (51.3 µm) compared to early (84.3 µm), intermediate (77.6 µm), and neovascular AMD (88.9 µm) groups. Choroidal thickness also showed notable reductions in the central and inner regions across all groups, with more pronounced thinning in the inner ring for atrophic AMD (-13%).

Reference
Costa I, Carvalho A, Andrade H, et al. Neurodegeneration and choroidal vascular features on OCT in the progression to advanced age-related macular degeneration. Int J Ophthalmol. 2025;18(1):103-110. doi: 10.18240/ijo.2025.01.12. PMID: 39829629; PMCID: PMC11672087.

 

This content is independent editorial sponsored by Astellas. Astellas had no input in the development of this content.

Share

Related Content

  • Geographic Atrophy

Spotlight on IZERVAY®

  • Geographic Atrophy

Two-year GATHER2 data show sustained GA growth reduction with avacincaptad pegol

  • Conference Roundup

Floretina 2025: study shows reduced treatment burden with EYP-1901 for neovascular AMD

3 Mins Watch
  • Geographic Atrophy

Over half of patients with dry AMD developed advanced disease in long-term analysis

  • Geographic Atrophy

Monthly avacincaptad pegol reduces geographic atrophy lesion growth for up to 3.5 years

  • Anterior Segment

Deep learning algorithm performs similarly to manual grading of GA on an OCT data set

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon